CVS Health (CVS) Tops Q1 EPS by 6c, Q2 EPS Guidance Tops Views

CVS Health (NYSE: CVS) reported Q1 EPS of $1.48, $0.06 better than the analyst estimate of $1.42. Revenue for the quarter came in at $45.7 billion versus the consensus estimate of $45.79 billion.

GUIDANCE:

CVS Health sees FY2018 EPS of $6.87-$7.08, versus the consensus of $6.22.

CVS Health sees Q2 EPS of $1.59-$1.64, versus the consensus of $1.42.

For earnings history and earnings-related data on CVS Health (CVS) click here.

You May Also Be Interested In

• Jabil (JBL) Tops Q3 EPS by 8c, Offers Guidance
• Micron Technology (MU) PT Raised to $1,300 at Bernstein SocGen Group
• John Wiley & Sons, Inc. (WLY) Tops Q4 EPS by 12c; offers outlook